130 related articles for article (PubMed ID: 10050549)
1. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation].
Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549
[TBL] [Abstract][Full Text] [Related]
2. [The effect of the antigens and strains of Yersinia pestis with the expression of different immunogenicity and virulence determinants on the level of lymphocyte blast transformation].
Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):4-5. PubMed ID: 8553746
[No Abstract] [Full Text] [Related]
3. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
Eyles JE; Butcher WA; Titball RW; Hill J
Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
[TBL] [Abstract][Full Text] [Related]
4. [Morphological study of the damaging effect of an EB vaccine strain of the plague microbe in inbred mice].
Nazarova LS; Isupov IV; Pavlova LP; Gor'kova AV; Dushkin VA
Biull Eksp Biol Med; 1988 Jun; 105(6):761-4. PubMed ID: 3390604
[TBL] [Abstract][Full Text] [Related]
5. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens].
Zadumina SIu; Nazarova LS; Isupov IV; Pavlova LP; Tikhomirova EI
Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):69-70. PubMed ID: 8553769
[No Abstract] [Full Text] [Related]
6. Construction of defined F1 negative mutants of virulent Yersinia pestis.
Worsham PL; Stein MP; Welkos SL
Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
[No Abstract] [Full Text] [Related]
7. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
8. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
[TBL] [Abstract][Full Text] [Related]
9. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
[TBL] [Abstract][Full Text] [Related]
10. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
Elvin SJ; Williamson ED
Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
[TBL] [Abstract][Full Text] [Related]
11. A dam mutant of Yersinia pestis is attenuated and induces protection against plague.
Robinson VL; Oyston PC; Titball RW
FEMS Microbiol Lett; 2005 Nov; 252(2):251-6. PubMed ID: 16188402
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
[TBL] [Abstract][Full Text] [Related]
13. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
Khan AA; Babu JP; Gupta G; Rao DN
Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
[TBL] [Abstract][Full Text] [Related]
15. [The biochemical aspects of the pathogenicity of the causative agent of plague].
Naumov AV; Kuz'michenko IA; Taranenko TM; Korovkin SA; Ermakova GV
Med Parazitol (Mosk); 1995; (4):17-22. PubMed ID: 8587511
[No Abstract] [Full Text] [Related]
16. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
[TBL] [Abstract][Full Text] [Related]
17. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
[TBL] [Abstract][Full Text] [Related]
18. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.
Palin A; Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
Vaccine; 2007 Jan; 25(4):741-50. PubMed ID: 16959385
[TBL] [Abstract][Full Text] [Related]
19. [The role of T-suppressors in the formation of plague immunity in mice].
Nazarova LS; Isupov IV; Surikov NN; Piontkovskiĭ SA; Devdariani ZL; Golubeva II; Taranenko TM; Alenkina TV
Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):89-93. PubMed ID: 2143614
[TBL] [Abstract][Full Text] [Related]
20. [The effect of a vaccinal strain of the plague microbe on C3-receptor expression on the surfaces of peritoneal and alveolar macrophages].
Vasil'eva GI; Tkachenko LN; Doroshenko EP; Gamleshko KhP; Balatskaia TA
Mikrobiol Z; 1994; 56(4):25-9. PubMed ID: 9181978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
